{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:55:32Z","timestamp":1791064532611,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jneuroim.2008.06.027","type":"journal-article","created":{"date-parts":[[2008,8,23]],"date-time":"2008-08-23T06:38:58Z","timestamp":1219473538000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["The myasthenia gravis thymus: A rare source of human autoantibody-secreting plasma cells for testing potential therapeutics"],"prefix":"10.1016","volume":"201-202","author":[{"given":"Marguerite E.","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Shiono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Newsom-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.06.027_bib1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0002-9440(10)61762-2","article-title":"Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers","volume":"159","author":"Armengol","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1042\/bj0680252","article-title":"Formation of specific antibodies and gamma-globulin in vitro; a study of the synthetic ability of various tissues from rabbits immunized by different methods","volume":"68","author":"Askonas","year":"1958","journal-title":"Biochem. J."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib3","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.47.6.1552","article-title":"A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis","volume":"47","author":"Beeson","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.027_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.34.1.66","article-title":"Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis","volume":"34","author":"Berrih","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.027_bib5","first-page":"462","article-title":"Microenvironments in the normal thymus and the thymus in myasthenia gravis","volume":"119","author":"Bofill","year":"1985","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00005792-194902000-00002","article-title":"The pathology of the thymus in myasthenia gravis: a study of 35 cases","volume":"28","author":"Castleman","year":"1949","journal-title":"Medicine"},{"key":"10.1016\/j.jneuroim.2008.06.027_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.112.1.17","article-title":"Rate of hemolytic antibody production by single cells in vivo in rabbits","volume":"112","author":"Conrad","year":"1974","journal-title":"J. Immunol."},{"issue":"Supple 204","key":"10.1016\/j.jneuroim.2008.06.027_bib8","first-page":"3","article-title":"Antibody production in relation to the development of plasma cells: in vivo and in vitro experiments","volume":"130","author":"Fagraeus","year":"1948","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib9","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/intimm\/9.9.1311","article-title":"Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library","volume":"9","author":"Farrar","year":"1997","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nm1288","article-title":"Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts","volume":"11","author":"Floto","year":"2005","journal-title":"Nat Med."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4049\/jimmunol.136.3.887","article-title":"Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis","volume":"136","author":"Fujii","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib12","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.158.4.1919","article-title":"Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies","volume":"158","author":"Graus","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib13","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.38.11.1784","article-title":"Anti-acetylcholine receptor antibody specificities in serum and in thymic cell culture supernatants from myasthenia gravis patients","volume":"38","author":"Heidenreich","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.027_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1365-2249.2002.02025.x","article-title":"Detection and characterization of plasma cells in peripheral blood: correlation of IgE+ plasma cell frequency with IgE serum titre","volume":"130","author":"Horst","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","article-title":"Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status","volume":"171","author":"Leite","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4049\/jimmunol.137.4.1221","article-title":"Antibodies to acetylcholine receptor and tetanus toxoid: in vitro synthesis by thymic lymphocytes","volume":"137","author":"Lisak","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","article-title":"Germinal centers","volume":"12","author":"MacLennan","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2141.2006.06181.x","article-title":"Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro","volume":"134","author":"Martin","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib19","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/01.LAB.0000032379.63784.9C","article-title":"Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen","volume":"82","author":"Matthews","year":"2002","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib20","first-page":"319","article-title":"Subpopulations of thyroid autoantibody-secreting lymphocytes in Graves' and Hashimoto thyroid glands","volume":"65","author":"McLachlan","year":"1986","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib21","first-page":"425","article-title":"Immunopathology of chronic nonspecific thyroiditis (autoimmune thyroiditis)","volume":"41","author":"Mellors","year":"1962","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib22","unstructured":"Menu, E., Asosingh, K., Indraccolo, S., De Raeve, H., Van Riet, I., Van Valckenborgh, E., Vande Broek, I., Fujii, N., Tamamura, H., Van Camp, B., Vanderkerken, K. 2006. The involvement of stromal derived factor-1alpha in homing and progression of multiple myeloma in the 5TMM model. 91, 605\u201312."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.126.1.109","article-title":"Resistance of long-lived lymphocytes and plasma cells in rat lymph nodes to treatment with prednisone, cyclophosphamide, 6-mercaptopurine, and actinomycin D","volume":"126","author":"Miller","year":"1967","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib24","doi-asserted-by":"crossref","first-page":"982","DOI":"10.4049\/jimmunol.98.5.982","article-title":"The radiation resistance of long-lived lymphocytes and plasma cells in mouse and rat lymph nodes","volume":"98","author":"Miller","year":"1967","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1751-553X.2007.01020.x","article-title":"Position statement on the use of bortezomib in multiple myeloma","volume":"30","author":"Morgan","year":"2008","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.coi.2006.03.004","article-title":"Stromal niches, plasma cell differentiation and survival","volume":"18","author":"Moser","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM198111263052203","article-title":"Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes","volume":"305","author":"Newsom-Davis","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib28","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"107","author":"Obeng","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2008.06.027_bib29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0008-8749(81)90160-X","article-title":"Reaginic antibody formation in the mouse. XI. Participation of long-lived antibody-forming cells in persistent antibody formation","volume":"58","author":"Okudaira","year":"1981","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib30","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.027_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-5728(02)00038-3","article-title":"Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis","volume":"125","author":"Roxanis","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1212\/WNL.31.8.935","article-title":"Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology","author":"Scadding","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.027_bib35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410220205","article-title":"Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study","volume":"22","author":"Schluep","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0896-8411(88)90067-4","article-title":"Myasthenia gravis thymus: clinical, histological and culture correlations","volume":"1","author":"Schluep","year":"1988","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1196\/annals.1254.026","article-title":"Scenarios for autoimmunization of T and B cells in myasthenia gravis","volume":"998","author":"Shiono","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/intimm\/dxg088","article-title":"Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor","volume":"15","author":"Shiono","year":"2003","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib39","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","article-title":"Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis","volume":"167","author":"Sims","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib40","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.20040719","article-title":"Targeting plasma cells in autoimmune diseases","volume":"199","author":"Tarlinton","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0165-5728(82)90035-2","article-title":"Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses","volume":"3","author":"Thomas","year":"1982","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(78)90073-9","article-title":"In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis","volume":"1","author":"Vincent","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.06.027_bib43","first-page":"614","article-title":"Appendix and M-antibody formation. VI. The functional anatomy of the rabbit appendix","volume":"28","author":"Waksman","year":"1973","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib44","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(77)92118-3","article-title":"Intrathymic pathogenesis and dual genetic control of myasthenia gravis","volume":"1","author":"Wekerle","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.06.027_bib45","first-page":"378","article-title":"Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes","volume":"54","author":"Willcox","year":"1983","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib46","first-page":"97","article-title":"Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis","volume":"58","author":"Willcox","year":"1984","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib47","first-page":"979","article-title":"Isolation of germinal centre (GC) cells is greatly improved by using the protease dispase to prepare cell suspensions","volume":"186","author":"Willcox","year":"1985","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib48","first-page":"1071","article-title":"Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects","volume":"73","author":"Willcox","year":"1989","journal-title":"Q. J. Med."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib49","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF00319736","article-title":"The thymus in seronegative myasthenia gravis patients","volume":"238","author":"Willcox","year":"1991","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib50","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni1440","article-title":"FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis","volume":"8","author":"Xiang","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.027_bib51","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2005-06-2269","article-title":"Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin","volume":"107","author":"Zand","year":"2006","journal-title":"Blood"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:10:06Z","timestamp":1759047006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808002051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":50,"alternative-id":["S0165572808002051"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.027","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The myasthenia gravis thymus: A rare source of human autoantibody-secreting plasma cells for testing potential therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}